Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Free Cash Flow (2018 - 2025)

Historic Free Cash Flow for Bioceres Crop Solutions (BIOX) over the last 8 years, with Q3 2025 value amounting to $15.0 million.

  • Bioceres Crop Solutions' Free Cash Flow rose 13385.76% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.2 million, marking a year-over-year increase of 11165.89%. This contributed to the annual value of $44.3 million for FY2025, which is 10865.56% up from last year.
  • As of Q3 2025, Bioceres Crop Solutions' Free Cash Flow stood at $15.0 million, which was up 13385.76% from $15.9 million recorded in Q2 2025.
  • Bioceres Crop Solutions' 5-year Free Cash Flow high stood at $24.6 million for Q1 2025, and its period low was -$511.3 million during Q1 2023.
  • For the 5-year period, Bioceres Crop Solutions' Free Cash Flow averaged around -$90.4 million, with its median value being -$5.1 million (2021).
  • Its Free Cash Flow has fluctuated over the past 5 years, first soared by 41814.69% in 2021, then plummeted by 860567.29% in 2022.
  • Bioceres Crop Solutions' Free Cash Flow (Quarter) stood at -$5.1 million in 2021, then crashed by 8351.95% to -$435.0 million in 2022, then dropped by 13.97% to -$495.8 million in 2023, then soared by 100.54% to $2.7 million in 2024, then surged by 466.64% to $15.0 million in 2025.
  • Its Free Cash Flow stands at $15.0 million for Q3 2025, versus $15.9 million for Q2 2025 and $24.6 million for Q1 2025.